Production (Stage)
Alterola Biotech, Inc.
ABTI
$0.001
-$0.0003-23.08%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -59.77% | -51.39% | -14.63% | 35.48% | 76.01% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -64.76% | -66.74% | -32.92% | -92.65% | -94.35% |
| Change in Net Operating Assets | 49.77% | 39.46% | 1,110.39% | 611.58% | -35.50% |
| Cash from Operations | -102.97% | -151.81% | -10.69% | -202.72% | -443.67% |
| Capital Expenditure | -- | 200.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -371.43% | -- | -- | -99.85% | 0.86% |
| Cash from Investing | -371.43% | 200.00% | -- | -99.85% | 0.86% |
| Total Debt Issued | 212.08% | 131.02% | 27.85% | -13.85% | 424.18% |
| Total Debt Repaid | -- | 200.00% | -- | 100.00% | 100.00% |
| Issuance of Common Stock | 1,410.34% | 1,410.34% | 654.97% | 1,422.27% | -99.65% |
| Repurchase of Common Stock | -153.58% | -1,409.94% | -1,409.94% | 98.50% | 98.50% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -212.33% | -- | -- | -194.37% | -200.00% |
| Cash from Financing | 177.79% | 119.09% | 22.49% | 110.30% | 3,001.48% |
| Foreign Exchange rate Adjustments | -287.24% | 124.39% | -152.53% | 107.00% | 153.61% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,349.15% | 2,822.09% | 88.89% | 63.00% | 96.33% |